ClinicalTrials.Veeva

Menu

Precision Immunology to Determine the Immune Response in Patients With COVID-19

U

University of Bonn

Status

Unknown

Conditions

SARS-CoV 2
COVID

Treatments

Other: Blood draw

Study type

Observational

Funder types

Other

Identifiers

NCT04360733
BOST-03

Details and patient eligibility

About

To better understand the immune response to SARS-CoV-2 infection, we devised a precision immunology approach to systematically study the immune function of different patient cohorts

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • SARS-Cov2 positive PCR

Exclusion criteria

  • pregnancy

Trial design

200 participants in 4 patient groups

asymptomatic Covid-19
Description:
Patients with confirmed SARS-CoV2 PCR but no clinical symptoms
Treatment:
Other: Blood draw
symptomatic Covid-19
Description:
Patients with confirmed SARS-CoV2 PCR and light clinical symptoms
Treatment:
Other: Blood draw
severe Covid-19
Description:
Patients with confirmed SARS-CoV2 PCR and severe clinical symptoms with ICU admission
Treatment:
Other: Blood draw
healthy controls
Description:
Persons with negative SARS-CoV2 PCR
Treatment:
Other: Blood draw

Trial contacts and locations

1

Loading...

Central trial contact

Christian Bode, MD; Folkert Steinhagen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems